Delayed tacrolimus is safe with basiliximab induction therapy
10.1053/jlts.2002.34679
Saved in:
Main Authors: | Lee, K.H., Da Costa, M., Lim, S.-G., Tan, K.-C. |
---|---|
Other Authors: | MEDICINE |
Format: | Others |
Published: |
2016
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/129547 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Treatment of steroid-resistant acute liver transplant rejection with Basiliximab
by: Fernandes, M.L., et al.
Published: (2011) -
Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transplant recipients: A preliminary experience
by: Aw, M.M., et al.
Published: (2013) -
Delayed Calcineurin Inhibitor Introduction Without Antibody Induction in Liver Transplantation Is Safe and Helps Preserve Kidney Function
by: Chutwichai Tovikkai, et al.
Published: (2022) -
Trough Level and Tacrolimus Variability of Early Converted Once-Daily Tacrolimus: 1-Year Follow-up Study
by: Sayamon Sukkha, et al.
Published: (2020) -
Population pharmacokinetics of tacrolimus in Asian paediatric liver transplant patients
by: Sam, W.J., et al.
Published: (2013)